C
CRA Clinical Trials
Clinical Research Associate (Monitor).
Local Context (Ireland/EU): The professional responsible for monitoring trial sites to ensure compliance with the protocol, GCP guidelines, and regulatory requirements.
CRF Clinical Trials
Case Report Form.
Local Context (Ireland/EU): A printed, optical, or electronic document designed to record all of the protocol-required information on each trial subject.
CRO Clinical Trials
Contract Research Organisation.
Local Context (Ireland/EU): A company providing support services to the pharmaceutical and biotech industries, managing clinical trials on behalf of sponsors.
CTIS Clinical Trials
Clinical Trials Information System.
Local Context (Ireland/EU): The single-entry portal managed by the EMA for submitting and evaluating clinical trials within the EU/EEA.
CTR Clinical Trials
Clinical Trials Regulation (EU No 536/2014).
Local Context (Ireland/EU): The harmonized EU regulation that entered into force in 2022, streamlining clinical trial approvals across the entire European Union.
I
ICF Clinical Trials
Informed Consent Form.
Local Context (Ireland/EU): The documentation demonstrating that a subject has voluntarily confirmed their willingness to participate in a trial after being fully informed.
Investigator Brochure Clinical Trials
The comprehensive compilation of clinical and non-clinical data on the investigational products under study.
Local Context (Ireland/EU): Must be updated annually by the sponsor and provided to principal investigators.
P
Phase I Clinical Trials
First-in-human clinical testing, typically performed in a small cohort of healthy volunteers (20-100) to evaluate safety and tolerability.
Local Context (Ireland/EU): LSO and REC approval is mandatory prior to recruitment.
Phase II Clinical Trials
Therapeutic exploratory testing in a cohort of patient volunteers (100-500) to assess efficacy, dosing ranges, and safety.
Local Context (Ireland/EU): Conducted across major teaching hospitals in Ireland under principal investigators.
Phase III Clinical Trials
Therapeutic confirmatory testing in large, diverse patient populations (1,000-5,000) to confirm clinical efficacy and monitor adverse reactions.
Local Context (Ireland/EU): Data from Phase III forms the bulk of the marketing authorization application (MAA).
Phase IV Clinical Trials
Post-marketing surveillance studies conducted after a medicine is authorized, evaluating long-term safety and real-world effectiveness.
Local Context (Ireland/EU): Often mandated by the EMA as part of post-authorization safety commitments.
Placebo Clinical Trials
An inactive substance designed to look identical to the active investigational drug, used as a control in trials.
Local Context (Ireland/EU): Used to isolate the clinical effect of the active pharmaceutical ingredient.